Quarterly funding report

Q3 2026 Singapore Startup Funding Report

8 funded Singaporean startups raised a combined $270.8M in Q3 2026. The biggest rounds, most active investors, and where the money went.

$270.8M
Total raised
8
Funding rounds
5
Active sectors

Top 8 funded companies

#CompanySectorRaisedProfile
1Acrab AI
$130M
Series B
View →
2K2 Therapeutics Health
$50M
Seed
View →
3Rize ClimateTech
$31M
Series B
View →
4Lingverse AI
$29M
Pre-seed
View →
5Graas Other
$17M
Series B
View →
6SimpleAI AI
$10M
View →
7K25 AI AI
$2M
View →
8optoML DeepTech
$1.8M
View →

Company names link to their site; “View” opens their Datapile profile. Ranked? Click “Badge” to embed it.

Funding by sector

AI4Health1ClimateTech1Other1DeepTech1

Most active investors

Notable rounds

Acrab is a Singapore-headquartered AI infrastructure startup developing a full-stack AI computing platform.

K2 Therapeutics is a Singapore-based biotech company focused on developing innovative therapies.

Rize is an agritech startup focused on reducing emissions from rice farming, which is a major contributor to global methane emissions.

Featured in this report?

If your company appears above, add the badge to your site to show you were featured in Datapile’s Q3 2026 Singapore funding report.

Embed this badge on your site
<a href="https://datapile.co/reports/q3-2026-singapore-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Singapore Funding Report</a>

Track every round as it happens

Datapile tracks Singaporean startup funding daily — with founder contacts, investor profiles, and full deal history.

Data from Datapile’s funding database. Generated August 2026.